Editorial| Volume 356, ISSUE 5, P411-412, November 2018

Coronary Artery Disease in Systemic Lupus Erythematosus

Published:August 31, 2018DOI:
      See Related Article on p. 451
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nilsson J
        Atherosclerotic plaque vulnerability in the statin era.
        Eur Heart J. 2017; 38: 1638-1644
        • Hansson GK
        • Hermansson A
        The immune system in atherosclerosis.
        Nat Immunol. 2011; 12: 204-212
        • Wigren M
        • Nilsson J
        • Kaplan MJ
        Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: Common mechanisms and possible targets for intervention.
        J Intern Med. 2015; 278: 494-506
        • Kahlenberg JM
        • Kaplan MJ
        Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.
        Annu Rev Med. 2013; 64: 249-263
        • Tsokos GC
        Systemic lupus erythematosus.
        N Engl J Med. 2011; 365: 2110-2121
        • Manzi S
        • Selzer F
        • Sutton-Tyrrell K
        • et al.
        Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.
        Arthritis Rheum. 1999; 42: 51-60
        • Baena-Diez JM
        • Garcia-Gil M
        • Comas-Cufi M
        • et al.
        Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.
        Heart. 2018; 104: 119-126
        • Li H
        • Tong Q
        • Guo L
        • et al.
        Risk of coronary artery disease in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
        Am J Med Sci. 2018; 356: 451-463
        • Esdaile JM
        • Abrahamowicz M
        • Grodzicky T
        • et al.
        Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.
        Arthritis Rheum. 2001; 44: 2331-2337
        • Hansson GK
        Inflammation, atherosclerosis, and coronary artery disease.
        N Engl J Med. 2005; 352: 1685-1695
        • Wigren M
        • Svenungsson E
        • Mattisson IY
        • et al.
        Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.
        Atherosclerosis. 2018; 270: 1-7

      Linked Article